Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Оценка качества жизни и сексуальной функции женщин, использующих интравагинальную гормональную систему НоваРинг
Оценка качества жизни и сексуальной функции женщин, использующих интравагинальную гормональную систему НоваРинг
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Yuzpe AA. Oral contraception: trends over time. J Reprod Med 2002; 47: 967–73.
2. Caruso S, Agnello C, Intelisano G et al. Prospective study on sexual behavior of women using 30 ?g etinylestradiol and 3 mg drospirenon oral contraceptive. Contraception 2005; 72: 19–23.
3. Ware JE, Kosinski M. SF-36 Physical and mental health summary scales: a manual for users of version 1, 2nd edn. Linciln: Quality Metric Incorporated, 2001.
4. Basson R, Berman J, Burnet A et al. Definition and classification of female sexual dysfunction: second report of the international consensus development conference on female sexual dysfunction. J Urol 2000; 163: 888–93.
5. Walton B, Trashawn T. Female sexual dysfunction. Curr Women's Health Reports 2003; 3: 319–26.
6. De Cherney AH. Hormone receptors and sexuality in the human female. J Women Health Gend Based Med 2000; S9: 9–13.
7. Berman JR. and Goldstein I. Female sexual dysfunction. Urol Clin North Am 2001; 28: 405–16.
8. Graziottin A. Libido: the biologic scenario. Maturitas 2000; 34 (Suppl. 1): S9–S16.
9. Oddens BJ. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauter-ine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception 1999; 59: 277–86.
10. Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 2001; 64: 51–8.
11. Caruso S, Agnello C, Intclisano G et al. Sexual behaviour of women taking low-dose oral contraceptive containing 15mg ethinylestradiol/60mg gestodene. Contraception 2004; 69: 237–40.
12. Guida M et al. Effects of two types of hormonal contraception – oral versus intravaginal – on the sexual life of women and their partners. Hum Reprod 2005; 20 (4): 1100–6.
13. Sabatini R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception 2006; 74: 220–3.
14. Ромащенко О.В., Мельников С.Н. Состояние сексуального здоровья женщин на фоне применения гормональной контрацепции. Акуше. и гинекол. 2007; 7: 63–7.
2. Caruso S, Agnello C, Intelisano G et al. Prospective study on sexual behavior of women using 30 ?g etinylestradiol and 3 mg drospirenon oral contraceptive. Contraception 2005; 72: 19–23.
3. Ware JE, Kosinski M. SF-36 Physical and mental health summary scales: a manual for users of version 1, 2nd edn. Linciln: Quality Metric Incorporated, 2001.
4. Basson R, Berman J, Burnet A et al. Definition and classification of female sexual dysfunction: second report of the international consensus development conference on female sexual dysfunction. J Urol 2000; 163: 888–93.
5. Walton B, Trashawn T. Female sexual dysfunction. Curr Women's Health Reports 2003; 3: 319–26.
6. De Cherney AH. Hormone receptors and sexuality in the human female. J Women Health Gend Based Med 2000; S9: 9–13.
7. Berman JR. and Goldstein I. Female sexual dysfunction. Urol Clin North Am 2001; 28: 405–16.
8. Graziottin A. Libido: the biologic scenario. Maturitas 2000; 34 (Suppl. 1): S9–S16.
9. Oddens BJ. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauter-ine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception 1999; 59: 277–86.
10. Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 2001; 64: 51–8.
11. Caruso S, Agnello C, Intclisano G et al. Sexual behaviour of women taking low-dose oral contraceptive containing 15mg ethinylestradiol/60mg gestodene. Contraception 2004; 69: 237–40.
12. Guida M et al. Effects of two types of hormonal contraception – oral versus intravaginal – on the sexual life of women and their partners. Hum Reprod 2005; 20 (4): 1100–6.
13. Sabatini R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception 2006; 74: 220–3.
14. Ромащенко О.В., Мельников С.Н. Состояние сексуального здоровья женщин на фоне применения гормональной контрацепции. Акуше. и гинекол. 2007; 7: 63–7.
2. Caruso S, Agnello C, Intelisano G et al. Prospective study on sexual behavior of women using 30 ?g etinylestradiol and 3 mg drospirenon oral contraceptive. Contraception 2005; 72: 19–23.
3. Ware JE, Kosinski M. SF-36 Physical and mental health summary scales: a manual for users of version 1, 2nd edn. Linciln: Quality Metric Incorporated, 2001.
4. Basson R, Berman J, Burnet A et al. Definition and classification of female sexual dysfunction: second report of the international consensus development conference on female sexual dysfunction. J Urol 2000; 163: 888–93.
5. Walton B, Trashawn T. Female sexual dysfunction. Curr Women's Health Reports 2003; 3: 319–26.
6. De Cherney AH. Hormone receptors and sexuality in the human female. J Women Health Gend Based Med 2000; S9: 9–13.
7. Berman JR. and Goldstein I. Female sexual dysfunction. Urol Clin North Am 2001; 28: 405–16.
8. Graziottin A. Libido: the biologic scenario. Maturitas 2000; 34 (Suppl. 1): S9–S16.
9. Oddens BJ. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauter-ine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception 1999; 59: 277–86.
10. Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 2001; 64: 51–8.
11. Caruso S, Agnello C, Intclisano G et al. Sexual behaviour of women taking low-dose oral contraceptive containing 15mg ethinylestradiol/60mg gestodene. Contraception 2004; 69: 237–40.
12. Guida M et al. Effects of two types of hormonal contraception – oral versus intravaginal – on the sexual life of women and their partners. Hum Reprod 2005; 20 (4): 1100–6.
13. Sabatini R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception 2006; 74: 220–3.
14. Ромащенко О.В., Мельников С.Н. Состояние сексуального здоровья женщин на фоне применения гормональной контрацепции. Акуше. и гинекол. 2007; 7: 63–7.
________________________________________________
2. Caruso S, Agnello C, Intelisano G et al. Prospective study on sexual behavior of women using 30 ?g etinylestradiol and 3 mg drospirenon oral contraceptive. Contraception 2005; 72: 19–23.
3. Ware JE, Kosinski M. SF-36 Physical and mental health summary scales: a manual for users of version 1, 2nd edn. Linciln: Quality Metric Incorporated, 2001.
4. Basson R, Berman J, Burnet A et al. Definition and classification of female sexual dysfunction: second report of the international consensus development conference on female sexual dysfunction. J Urol 2000; 163: 888–93.
5. Walton B, Trashawn T. Female sexual dysfunction. Curr Women's Health Reports 2003; 3: 319–26.
6. De Cherney AH. Hormone receptors and sexuality in the human female. J Women Health Gend Based Med 2000; S9: 9–13.
7. Berman JR. and Goldstein I. Female sexual dysfunction. Urol Clin North Am 2001; 28: 405–16.
8. Graziottin A. Libido: the biologic scenario. Maturitas 2000; 34 (Suppl. 1): S9–S16.
9. Oddens BJ. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauter-ine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception 1999; 59: 277–86.
10. Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 2001; 64: 51–8.
11. Caruso S, Agnello C, Intclisano G et al. Sexual behaviour of women taking low-dose oral contraceptive containing 15mg ethinylestradiol/60mg gestodene. Contraception 2004; 69: 237–40.
12. Guida M et al. Effects of two types of hormonal contraception – oral versus intravaginal – on the sexual life of women and their partners. Hum Reprod 2005; 20 (4): 1100–6.
13. Sabatini R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception 2006; 74: 220–3.
14. Ромащенко О.В., Мельников С.Н. Состояние сексуального здоровья женщин на фоне применения гормональной контрацепции. Акуше. и гинекол. 2007; 7: 63–7.
Авторы
И.В.Кузнецова, Л.Н.Морозова, В.А.Коновалов
Кафедра акушерства и гинекологии №1 лечебного факультета ММА им. И.М.Сеченова
Кафедра акушерства и гинекологии №1 лечебного факультета ММА им. И.М.Сеченова
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.